Elmos: Significant recovery in current Q4 2020 – full-year guidance 2020 above market expectations

Q3 2020 at the upper end of guidance range: Sales at 40.9 million Euro / EBIT at -10.5 million Euro

Read more

Ad hoc: Significant recovery in current Q4 2020 – full-year guidance 2020 above market expectations

Public disclosure of insider information pursuant to Art. 17 MAR

Read more

Elmos: Management Board contract of Dr. Jan Dienstuhl prematurely extended until the end of 2023

Elmos meets forecast for the second quarter 2020 – turning point in the current quarter

Q2 2020: Sales at 58.8 million Euro / EBIT margin at 5.4%

Read more

Ad hoc: Elmos Q3 2020 forecast below consensus – turning point in the current quarter

Public disclosure of insider information pursuant to Art. 17 MAR

Read more
Show cookie popup